Improving fundamentals and stabilizing technical baseline. Base building process active. Valuations remain conservative and supported by current metrics.
SENTINEL REVIEW
20 Microns Limited (20MICRONS)•Updated yesterday
🛡️ Sound Structural Profile: In FY2026, 20 Microns Limited reports a 6.7% YoY growth in PAT to ₹66.7 Cr, supported by strong operating cash flows of ₹103.6 Cr and a CFO/PAT ratio of 1.55. Historical monitoring signals around earnings quality and inventory stress are currently easing as revenue momentum improves and cash generation strengthens. Balance sheet integrity remains firm, with D/E at 0.3 and total debt of ₹145.8 Cr. Temporary working-capital friction—reflected in receivable days rising to 57.4 and a 225.9% YoY growth in operating cash flow—remains contained, keeping 20 Microns Limited within Flagium’s stable surveillance range.
- ✗Risk score deteriorated (QoQ change: +5 pts)
- ✗Profitability margins remain stressed
- ✗New risk trigger: Inventory Stress (+18 pts)
- ✓Growth expectations are conservative
- ✓Market structure is neutral/stabilizing
- ✗Institutional flow regime is Strong Distribution (-2.35σ)
- ✗Share price is down -25.0% this quarter (from ₹214.59 on 30 Sept to ₹161.04)
- 🔴Investigate Inventory Stress and balance sheet impact
- 🟠Track earnings quality and working capital trends in next filing
- 🟢Maintain routine quarterly surveillance; no governance escalation required
- 3.0 ptsGrowth Sustainability
- 2.0 ptsBalance Sheet Stress
Divergence Radar
Structural Matrix
Risk vs Price TimelineVisualizing the historical relationship between the structural risk score and stock price movement over time.
| Duration | Perf. | Sector Avg | Divergence |
|---|---|---|---|
| 1 Week | -10.7% | -1.46% | -9.24% |
| 1 Month | -24.37% | -6.69% | -17.68% |
| 6 Months | -8.96% | +6.82% | -15.78% |
| 1 Year | -23.08% | +8.93% | -32.01% |
| 2 Year | -42.8% | +47.64% | -90.44% |
| 3 Year | +18.53% | +125.5% | -106.96% |
Business Analysis Methodology
Business analysis focuses on structural risk inside the company. Flagium monitors earnings quality, balance sheet strength, liquidity, governance, competitive position, and growth sustainability to identify areas where risk may be increasing or decreasing before it becomes obvious in reported results.
Financial profile remains stable for now. Weakness is detected in growth sustainability. No immediate concerns are visible. Risk is increasing at a faster pace.
Risk Score Composition
Investment Risk Thesis
Current risk score has remained stable (5 → 5) over 12 quarters.
- Inventory turnover
- Operating profit margins
Risk Drivers (Active Warnings)
Primary Driver & Insights
Asset turnover is slowing down due to inventory accumulation. This indicates potential channel stuffing or weaker demand in core product segments.
Active Risk Objects (6)Free Preview (2 of 6)
Inventory growth (12.1%) significantly outpaced revenue growth (3.1%).
Stock is piling up in the warehouse. Inventory turnover is slowing down dangerously.
20MICRONS: Inventory growth outpaced Revenue growth by +33.5 pp (Inventory holding ratio increased +36.9%).
Slight build-up in inventory detected. Monitor for slowing sales momentum.
Unlock All 6 Forensic Signals (4 Additional Warnings Gated)
Free accounts preview the top 2 highest-impact warning signals. Upgrade to Flagium Pro to inspect all 6 active forensic detectors, multi-quarter duration streaks, and financial stress metrics for 20 Microns Limited.
Statutory Note: Forensic signals are algorithmic quantitative observations derived from publicly filed XBRL disclosures and do not constitute allegations of legal misconduct or investment recommendations.
Unlock Interactive Signal Evidence Dossier
Access complete multi-quarter financial evidence, 5-KPI snapshot strips, diagnostic hypotheses, and 1-page forensic PDF dossiers for 20 Microns Limited.
Structural Risk Attribution
Deterministic quarter-on-quarter causal decomposition grounded in statutory exchange filings.
Structural History · Last 12 QuartersHistorical Trajectory (12Q)
Risk deteriorated moderately (+5.0 pts), driven by new Inventory Stress (+18.0 pts) and new Universal Inventory Divergence (+6.7 pts).
Business Resilience & Benchmark Context
Overall: STRONGPEER COMPARISON MATRIX
Ranked surveillance & credit risk comparison against sector peers
Stable
Stable
Watch
Watch
Watch
Moderate Deterioration
* Peer comparison is based on risk signals, not valuation or returns.
Unlock 5-Year Forensic Divergence Cockpit
Access multi-year visual divergence charts (EBITDA vs CFO Cash Gap, Receivables Decoupling Spread, and Debt vs FCF Burn) for 20 Microns Limited.
FINANCIAL STATEMENTS
Working Capital & Forensic Monitor
Operating Cycle Disclosures·10 Fiscal Years
Working Capital Schedule (INR Cr)
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Trade Receivables(₹ Cr) | 177 | 143 | 126 | 97 | — | — | — | — | — | — |
Inventories(₹ Cr) | 142 | 160 | 113 | 115 | — | — | — | — | — | — |
Trade Payables(₹ Cr) | 61 | 68 | 63 | 79 | — | — | — | — | — | — |
Net Working Capital(₹ Cr) | 258 | 235 | 175 | 134 | — | — | — | — | — | — |
Working Capital / Sales(%) | 26.9% | 25.6% | 22.4% | 19.0% | — | — | — | — | — | — |
Cash Conversion & Operating Cycle (Days)
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash Conversion Cycle (CCC)(days) | 98d | 94d | 83d | 69d | — | — | — | — | — | — |
Debtor Days (DSO)(days) | 67d | 57d | 59d | 50d | — | — | — | — | — | — |
Inventory Days (DIO)(days) | 54d | 64d | 53d | 60d | — | — | — | — | — | — |
Creditor Days (DPO)(days) | 23d | 27d | 29d | 41d | — | — | — | — | — | — |
Forensic Accounting Monitor & Divergences
| Metric / Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Receivable Growth vs Sales (Δ)(%) | +18.7% | -3.2% | +17.9% | — | — | — | — | — | — | — |
Inventory Growth vs Sales (Δ)(%) | -15.7% | +24.3% | -13.0% | — | — | — | — | — | — | — |
Asset Growth vs Sales (Δ)(%) | +1.1% | +3.8% | +1.7% | — | — | — | — | — | -5.3% | — |
Earnings-to-Cash Divergence (PAT - CFO)(₹ Cr) | -37 | 31 | 2 | -21 | -1 | — | — | — | -42 | -28 |
Accrual Ratio (Accruals / Avg Assets)(%) | -5.0% | 4.7% | 0.3% | -4.0% | — | — | — | — | -11.4% | -7.7% |
Operating Cash Realisation (CFO / EBITDA)(%) | 113.0% | 37.5% | 69.5% | 110.7% | 74.1% | — | — | — | 101.7% | 78.6% |
Capitalisation Intensity (CWIP / Assets)(%) |